Sangamo Therapeutics (SGMO) Misses Q3 EPS by 13c
Tweet
Share
E-mailGet Alerts SGMO Hot Sheet
Price: $0.18 --0%
Financial Fact:
Collaboration agreements: 2.73M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Financial Fact:
Collaboration agreements: 2.73M
Today's EPS Names:
VIVO, PMCB, PLCE, More
Join SI Premium – FREE
Sangamo Therapeutics (NASDAQ: SGMO) reported Q3 EPS of ($0.13), $0.13 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $23.6 million versus the consensus estimate of $26.96 million.
For earnings history and earnings-related data on Sangamo Therapeutics (SGMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- John Wiley & Sons, Inc. (WLY) Tops Q1 EPS by 4c ; Offers Guidance
- Mama's Creations, Inc. (MAMA) Tops Q3 EPS by 1c
- Docusign Inc. (DOCU) Tops Q2 EPS by 8c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
